Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
A. Rachel Leheny currently holds 317,655 shares of Anthera Pharmaceuticals Inc (ANTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, A. Rachel Leheny has been a net buyer of ANTH stock. They have purchased $839.3K and sold $0 worth of shares.
A. Rachel Leheny's most recent insider trade was on Jun 25, 2026, when they sold 186,729 shares at $0.80 per share.
A. Rachel Leheny serves as Executive at Anthera Pharmaceuticals Inc (ANTH). They have executed 35 insider transactions totaling $839.3K over their tenure at the company.
A. Rachel Leheny holds the position of Executive at Anthera Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
A. Rachel Leheny has shown a buying trading pattern, with $839.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by A. Rachel Leheny was on Mar 4, 2010, when they purchased $1.4M worth of ANTH shares. This transaction involved 215,495 shares at $6.58 per share.
A. Rachel Leheny currently owns 317,655 shares of Anthera Pharmaceuticals Inc (ANTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of A. Rachel Leheny's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. A. Rachel Leheny has 35 Form 4 filings on record as an insider at Anthera Pharmaceuticals Inc.
Set alerts for A. Rachel Leheny and 40,000+ other insiders.